RNA analysis research covers a wide range of topics-from large-scale analysis of the transcriptome-the complete set of RNA transcripts encoded by a genome-to studying the actions of individual small noncoding RNAs on specific genes. According to latest analysis by Publisher, the global RNA analysis market is projected to climb to USD 14,750 million by 2028-end, progressing at a CAGR of 9.1% during 2022-2028. The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global RNA analysis market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the RNA analysis industry.
Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globallyDownload Sample
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the technology, and region. The global market for RNA analysis can be segmented by technology: microarrays, polymerase chain reaction (PCR), RNAi gene silencing, sequencing technologies. In 2021, the polymerase chain reaction segment made up the largest share of revenue generated by the RNA analysis market. RNA analysis market is further segmented by region: Asia Pacific, Europe, North America, MEA (Middle East and Africa), Latin America. North America was the largest contributor to the global RNA analysis market in 2021. By technology: - microarrays - polymerase chain reaction (PCR) - RNAi gene silencing - sequencing technologies By region: - Asia Pacific - Europe - North America - MEA (Middle East and Africa) - Latin America
The report explores the recent developments and profiles of key vendors in the Global RNA Analysis Market, including Agilent Technologies Inc., Bio-Rad Laboratories, Inc., CD Genomics, Danaher Corp., Eurofins Scientific, Fluidigm Corp., Illumina, Inc., Merck KGaA, Promega Corp., Qiagen N.V., Roche Holding AG, Thermo Fisher Scientific Inc., among others. *REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES Historical & Forecast Period This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year. Scope of the Report - To analyze and forecast the market size of the global RNA analysis market. - To classify and forecast the global RNA analysis market based on technology, region. - To identify drivers and challenges for the global RNA analysis market. - To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global RNA analysis market. - To identify and analyze the profile of leading players operating in the global RNA analysis market.
Why Choose This Report - Gain a reliable outlook of the global RNA analysis market forecasts from 2022 to 2028 across scenarios. - Identify growth segments for investment. - Stay ahead of competitors through company profiles and market data. - The market estimate for ease of analysis across scenarios in Excel format. - Strategy consulting and research support for three months. - Print authentication provided for the single-user license.